Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Hutchison MediPharma Limited sold an option on its...
ChinaBio® Today profiled Sinoasis Pharmaceuticals,...
Simcere Pharma (先声药业) will...
Jiangsu Hengrui Medicine received FDA approval to begin...
China has ordered 7.3 million doses of H1N1 flu vaccine...
Jiangsu Yanshen Biological Technology Stock Co. was given...
Boehringer Ingelheim will invest $149 million in China...
PPD, Inc., a US-based CRO, agreed to acquire Excel...
China currently ranks number two in the world in the...
The 7th ChinaBio® Investor Forum granted “Most...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
